Guest Editorial Understanding genes isn’t enough to stop cancer—it’s time to use a systems approach to tackle metastasis July 22, 2022Vol.48 No.29By Joan Massagué and Marie-Josée Kravis
FreeObituary Jerome Carl Landry, radiation oncologist at Emory and Grady, dies at 66 July 22, 2022Vol.48 No.29By Winship Cancer Institute of Emory University news staff
FreeWhite House Monica Bertagnolli, first woman and first clinical trials group chair to direct the National Cancer Institute July 21, 2022Vol.48 No.29By Paul Goldberg and Matthew Bin Han Ong
Trials & Tribulations All colorectal cancer patients require germline testing at diagnosis and somatic testing at advanced disease diagnosis July 15, 2022Vol.48 No.28By Wenora Johnson, Danielle Ripley-Burgess, Heather Hampel, Folasade (Fola) P. May, Anjee Davis and Richard M. Goldberg
Capitol Hill NIH-funded institutions must report sexual misconduct cases within 30 days, effective July 9 July 15, 2022Vol.48 No.28By Matthew Bin Han Ong
Capitol HillConversation with The Cancer Letter Shikha Jain, Shea Holman examine NIH’s new requirements for institutions to report misconduct July 15, 2022Vol.48 No.28By Matthew Bin Han Ong
FreeObituary Herman Suit, whose research underpinned precision radiation and proton beam therapy, dies at 93 July 15, 2022Vol.48 No.28By Anthony L. Zietman
FreeIn the Archives John Ultmann: Founding director of UChicago Cancer Research Center July 15, 2022Vol.48 No.28
Trials & Tribulations Burnout from the elusive quest for quality July 15, 2022Vol.48 No.28By Banu E. Symington
